Lazaros J Lekakis MD

PubMed

• Extracorporeal Photopheresis for Chronic Graft-Versus-Host Disease According to 2014 NIH Consensus Criteria.
  Yitzhar Goretsky, Noa Holtzman, Sunwoo Han, Isildinha M Reis, Vera Suzuki
  Journal of Clinical Apheresis. 2025-12-01
• RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT.
  Zachariah DeFilipp, Hannah Choe, Yvonne A Efebera, Ayman Saad, Shatha Farhan
  Blood. 2025-10-23
• Psychosocial correlates of failure to complete hematopoietic stem cell transplants in a diverse population.
  Maria Rueda-Lara, Ingrid Barrera, Krishna V Komanduri, Denise Pereira, Lazaros Lekakis
  Bone Marrow Transplantation. 2025-09-01

Abstracts/Posters

• CD19-Loss with Preservation of Other B Cell Lineage Features in Patients with Large B Cell Lymphoma Who Relapsed Post_Axi-Cel
  Lazaros J. Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
  Lazaros J Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
  Lazaros J Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Comparison of Two-Year Outcomes in ZUMA-1 (Axicabtagene Ciloleucel) and SCHOLAR-1 in Patients with Refractory Large B Cell Lymphoma
  Lazaros J Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Experience with Axicabtagene Ciloleucel (Axi-cel) in Patients with Secondary CNS Involvement: Results from the US Lymphoma CAR T Consortium
  Lazaros J. Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018